Pharmaceutical News and Articles

Certain Oral Bacteria Tied to Risk for New Head, Neck Squamous Cell Cancer

Certain oral bacteria are a risk factor for development of head and neck squamous cell cancer (HNSCC), according to a study published online Sept. 26 in JAMA On

Six in 10 Americans Have Unhealthy Pro-Inflammatory Diets

even sleep is a key component, Meadows said. Diet can be used as a tool to combat that. More informationJohns Hopkins Medicine has an anti-inflammatory diet gui

1 in 14 U.S. Hospital Patients Fall Victim to Harmful Diagnostic Errors

One in 14 hospital patients may be the victim of damaging diagnostic mistakes, new research suggests.The finding is from a study of 675 patients admitted to one

Coffee, Water, Soda: Which Raise Your Odds for Stroke?

to a 22 higher risk of stroke. And, it added, risk rose sharply among those who drank two or more of these beverages a day. Researchers noted that many products

George the Frenchie's Cancer Journey May Help Other Dogs and Even Children

to discover that the tumor had entered George s spinal canal. This tumor was way more invasive than we could have ever imagined. The prior imaging with radiogra

Restrictive State Laws Tied to Higher Suicide Risk for Trans Youth

deserve dignity, respect, and the ability to lead healthy and full lives. Dr. Jack Turban, director of the gender psychiatry program at the University of Califo

Higher Doses of Buprenorphine May Improve Treatment Outcomes for People with Opioid Use Disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent e

AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie (NYSE ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a monotherapy in early Parkinson s disease.

Eirion Therapeutics Announces Results of First-in-Human Clinical Trial Evaluating Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles

WOBURN, Mass., Oct. 1, 2024. Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, an

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation